The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient reported outcomes (PROs) of multiple myeloma (MM) patients treated with panobinostat (PAN) after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled, PANORAMA-1 trial.
 
Paul G. Richardson
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genmab; Johnson & Johnson; Millennium; Novartis; Oncopeptides
Research Funding - Celgene; Millennium
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Robert L. Schlossman
Consulting or Advisory Role - Millennium; Onyx
 
Anuja Nidumolu Roy
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
 
Istvan Majer
Research Funding - Abbvie; Bristol-Myers Squibb; Janssen; Merck; Novartis
Other Relationship - Pharmerit
 
Ashok Panneerselvam
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Monika Sopala
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Jesus San Miguel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; MDS Nordion; Millennium; Novartis; Onyx